Literature DB >> 33928579

Cationic Dendrimers for siRNA Delivery: An Overview of Methods for In Vitro/In Vivo Characterization.

Erik Laurini1, Suzana Aulic2, Domenico Marson2, Maurizio Fermeglia2, Sabrina Pricl2,3.   

Abstract

This chapter reviews the different techniques for analyzing the chemical-physical properties, transfection efficiency, cytotoxicity, and stability of covalent cationic dendrimers (CCDs) and self-assembled cationic dendrons (ACDs) for siRNA delivery in the presence and absence of their nucleic cargos. On the basis of the reported examples, a standard essential set of techniques is described for each step of a siRNA/nanovector (NV) complex characterization process: (1) analysis of the basic chemical-physical properties of the NV per se; (2) characterization of the morphology, size, strength, and stability of the siRNA/NV ensemble; (3) characterization and quantification of the cellular uptake and release of the siRNA fragment; (4) in vitro and (5) in vivo experiments for the evaluation of the corresponding gene silencing activity; and (6) assessment of the intrinsic toxicity of the NV and the siRNA/NV complex.

Entities:  

Keywords:  Cationic dendrimer; Experimental characterization; PAMAM dendrimers; Self-assembling nanocarriers; siRNA delivery

Year:  2021        PMID: 33928579     DOI: 10.1007/978-1-0716-1298-9_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  91 in total

1.  Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing.

Authors:  Paola Posocco; Xiaoxuan Liu; Erik Laurini; Domenico Marson; Chao Chen; Cheng Liu; Maurizio Fermeglia; Palma Rocchi; Sabrina Pricl; Ling Peng
Journal:  Mol Pharm       Date:  2013-07-25       Impact factor: 4.939

Review 2.  The current state and future directions of RNAi-based therapeutics.

Authors:  Ryan L Setten; John J Rossi; Si-Ping Han
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

Review 3.  Exploration of biomedical dendrimer space based on in-vivo physicochemical parameters: Key factor analysis (Part 2).

Authors:  Serge Mignani; João Rodrigues; René Roy; Xiangyang Shi; Valentin Ceña; Saïd El Kazzouli; Jean-Pierre Majoral
Journal:  Drug Discov Today       Date:  2019-03-21       Impact factor: 7.851

Review 4.  Clinical advances of siRNA therapeutics.

Authors:  Bo Hu; Yuhua Weng; Xin-Hua Xia; Xing-Jie Liang; Yuanyu Huang
Journal:  J Gene Med       Date:  2019-06-17       Impact factor: 4.565

5.  Entering the Modern Era of Gene Therapy.

Authors:  Xavier M Anguela; Katherine A High
Journal:  Annu Rev Med       Date:  2018-11-26       Impact factor: 13.739

Review 6.  Optimization of siRNA delivery to target sites: issues and future directions.

Authors:  Ikramy A Khalil; Yuma Yamada; Hideyoshi Harashima
Journal:  Expert Opin Drug Deliv       Date:  2018-09-25       Impact factor: 6.648

Review 7.  Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.

Authors:  Tamkin Ahmadzada; Glen Reid; David R McKenzie
Journal:  Biophys Rev       Date:  2018-01-11

8.  PAMAM dendrimers for siRNA delivery: computational and experimental insights.

Authors:  Giovanni Maria Pavan; Paola Posocco; Aaron Tagliabue; Marek Maly; Anastasia Malek; Andrea Danani; Enzio Ragg; Carlo V Catapano; Sabrina Pricl
Journal:  Chemistry       Date:  2010-07-12       Impact factor: 5.236

9.  The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpression.

Authors:  Dirk Grimm
Journal:  Silence       Date:  2011-10-26

Review 10.  Dendrimers as carriers for siRNA delivery and gene silencing: a review.

Authors:  Jiangyu Wu; Weizhe Huang; Ziying He
Journal:  ScientificWorldJournal       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.